Cystic Fibrosis — Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease
Citation(s)
Multi-Center, Double-Blind, Randomized, Placebo-Controlled, 28-Day Study of INS37217 Inhalation Solution in Subjects With Mild to Moderate Cystic Fibrosis Lung Disease